Mucin hypersecretion inhibitors and methods of use
US7524926B2 · kind B2 · utility
6Cited by
10References
55Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 20, 2006 |
| Grant date | Apr 28, 2009 |
| Priority date | — |
| Expiry date | May 7, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides are provided that comprise less than 24 amino acids. The peptides have an amino acid sequence selected from the group consisting of: (a) an amino acid sequence having from 4 to 23 contiguous amino acids of a reference sequence PEPTIDE 1; (b) an amino acid sequence substantially identical to the sequence defined in (a); and (c) a variant of the amino acid sequence defined in (a). Also provided is a non-myristoylated MANS peptide. Various methods of using the peptides are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.